Modelling and simulation to improve decision-making in clinical development
2005; Wiley; Volume: 4; Issue: 1 Linguagem: Inglês
10.1002/pst.153
ISSN1539-1612
AutoresCarl‐Fredrik Burman, Bengt Hamrén, Per Olsson,
Tópico(s)Pharmaceutical studies and practices
ResumoModelling and simulation are buzz words in clinical drug development. But is clinical trial simulation (CTS) really a revolutionary technique? There is not much more to CTS than applying standard methods of modelling, statistics and decision theory. However, doing this in a systematic way can mean a significant improvement in pharmaceutical research. This paper describes in simple examples how modelling could be used in clinical development. Four steps are identified: gathering relevant information about a drug and the disease; building a mathematical model; predicting the results of potential future trials; and optimizing clinical trials and the entire clinical programme. We discuss these steps and give a number of examples of model components, demonstrating that relatively unsophisticated models may also prove useful. We stress that modelling and simulation are decision tools and point out the benefits of integrating them with decision analysis. Copyright © 2005 John Wiley & Sons, Ltd.
Referência(s)